Search: onr:"swepub:oai:DiVA.org:liu-151805" >
Intratumor Heteroge...
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
-
- Lindstrom, Linda S. (author)
- Karolinska Institutet,Karolinska Inst, Sweden
-
- Yau, Christina (author)
- Univ Calif San Francisco, CA USA; Buck Inst Res Aging, CA USA
-
- Czene, Kamila (author)
- Karolinska Institutet,Karolinska Inst, Sweden
-
show more...
-
- Thompson, Carlie K. (author)
- Univ Calif San Francisco, CA USA
-
- Hoadley, Katherine A. (author)
- Univ North Carolina Chapel Hill, NC USA
-
- vant Veer, Laura J. (author)
- Univ Calif San Francisco, CA 94140 USA; Univ Calif San Francisco, CA 94143 USA
-
- Balassanian, Ron (author)
- Univ Calif San Francisco, CA 94140 USA
-
- Bishop, John W. (author)
- Univ Calif Davis, CA 95616 USA
-
- Carpenter, Philip M. (author)
- Univ Southern Calif, CA USA; Univ Calif Irvine, CA USA
-
- Chen, Yunn-Yi (author)
- Univ Calif San Francisco, CA 94140 USA
-
- Datnow, Brian (author)
- Univ Calif San Diego, CA 92093 USA
-
- Hasteh, Farnaz (author)
- Univ Calif San Diego, CA 92093 USA
-
- Krings, Gregor (author)
- Univ Calif San Francisco, CA 94140 USA
-
- Lin, Fritz (author)
- Univ Calif Irvine, CA USA
-
- Zhang, Yanhong (author)
- Univ Calif Davis, CA 95616 USA
-
- Nordenskjöld, Bo (author)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US
-
- Stål, Olle (author)
- Linköpings universitet,Avdelningen för Kirurgi, Ortopedi och Onkologi,Medicinska fakulteten,Region Östergötland, Onkologiska kliniken US
-
- Benz, Christopher C. (author)
- Univ Calif San Francisco, CA USA; Buck Inst Res Aging, CA USA
-
- Fornander, Tommy (author)
- Karolinska Institutet,Karolinska Inst, Sweden
-
- Borowsky, Alexander D. (author)
- Univ Calif Davis, CA 95616 USA
-
- Esserman, Laura J. (author)
- Univ Calif San Francisco, CA USA
-
show less...
-
(creator_code:org_t)
- 2018-01-19
- 2018
- English.
-
In: Journal of the National Cancer Institute. - : OXFORD UNIV PRESS INC. - 0027-8874 .- 1460-2105. ; 110:7, s. 726-733
- Related links:
-
https://academic.oup...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Background: Breast cancer patients with estrogen receptor (ER)-positive disease have a continuous long-term risk for fatal breast cancer, but the biological factors influencing this risk are unknown. We aimed to determine whether high intratumor heterogeneity of ER predicts an increased long-term risk (25 years) of fatal breast cancer. Methods: The STO-3 trial enrolled 1780 postmenopausal lymph node-negative breast cancer patients randomly assigned to receive adjuvant tamoxifen vs not. The fraction of cancer cells for each ER intensity level was scored by breast cancer pathologists, and intratumor heterogeneity of ER was calculated using Raos quadratic entropy and categorized into high and low heterogeneity using a predefined cutoff at the second tertile (67%). Long-term breast cancer-specific survival analyses by intra-tumor heterogeneity of ER were performed using Kaplan-Meier and multivariable Cox proportional hazard modeling adjusting for patient and tumor characteristics. Results: A statistically significant difference in long-term survival by high vs low intratumor heterogeneity of ER was seen for all ER-positive patients (P amp;lt; .001) and for patients with luminal A subtype tumors (P = .01). In multivariable analyses, patients with high intratumor heterogeneity of ER had a twofold increased long-term risk as compared with patients with low intratumor heterogeneity (ER-positive: hazard ratio (HR] = 1.98, 95% confidence interval (CI] = 1.31 to 3.00; luminal A subtype tumors: HR = 2.43, 95% CI -1.18 to 4.99). Conclusions: Patients with high intratumor heterogeneity of ER had an increased long-term risk of fatal breast cancer. Interestingly, a similar long-term risk increase was seen in patients with luminal A subtype tumors. Our findings suggest that intratumor heterogeneity of ER is an independent long-term prognosticator with potential to change clinical management, especially for patients with luminal A tumors.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Lindstrom, Linda ...
-
Yau, Christina
-
Czene, Kamila
-
Thompson, Carlie ...
-
Hoadley, Katheri ...
-
vant Veer, Laura ...
-
show more...
-
Balassanian, Ron
-
Bishop, John W.
-
Carpenter, Phili ...
-
Chen, Yunn-Yi
-
Datnow, Brian
-
Hasteh, Farnaz
-
Krings, Gregor
-
Lin, Fritz
-
Zhang, Yanhong
-
Nordenskjöld, Bo
-
Stål, Olle
-
Benz, Christophe ...
-
Fornander, Tommy
-
Borowsky, Alexan ...
-
Esserman, Laura ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Journal of the N ...
- By the university
-
Linköping University
-
Karolinska Institutet